Cargando…

Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies

As global competition intensifies, research and development (R & D) organizations need to enhance their strategic management in order to become goal-directed communities for innovation and allocate their resources consistent with their overall R & D strategy. The world pharmaceutical market...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasekh, Hamid Reza, Mehralian, Gholamhossein, Vatankhah-Mohammadabadi, Abbas Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813171/
https://www.ncbi.nlm.nih.gov/pubmed/24250532
_version_ 1782289064893874176
author Rasekh, Hamid Reza
Mehralian, Gholamhossein
Vatankhah-Mohammadabadi, Abbas Ali
author_facet Rasekh, Hamid Reza
Mehralian, Gholamhossein
Vatankhah-Mohammadabadi, Abbas Ali
author_sort Rasekh, Hamid Reza
collection PubMed
description As global competition intensifies, research and development (R & D) organizations need to enhance their strategic management in order to become goal-directed communities for innovation and allocate their resources consistent with their overall R & D strategy. The world pharmaceutical market has undergone fast, unprecedented, tremendous and complex changes in the last several years. The pharmaceutical industry is today still one of the most inventive, innovative and lucrative of the so-called “high-tech” industries. This industry serves a dual role in modern society. On one hand, it is a growing industry, and its output makes a direct contribution to gross domestic product (GDP). On the other side, drugs, this industry’s major output, are an input in the production of good health. The purpose of this study is to evaluate R & D activities of pharmaceutical companies, and also to highlight critical factors which have influential effect on results of these activities. To run this study a valid questionnaire based on literature review and experts’ opinion was designed and delivered to 11 pharmaceutical companies. Empirical data show there is not acceptable situations considering of the factors that should be taken in to account by managers including; management commitment, human resource management, information technology and financial management. Furthermore, we concluded some interesting results related to different aspects of R & D management. In conclusion, managers must be aware about their performance in R & D activities, accordingly they will able to take a comprehensive policy in both national and within the company.
format Online
Article
Text
id pubmed-3813171
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-38131712013-11-18 Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies Rasekh, Hamid Reza Mehralian, Gholamhossein Vatankhah-Mohammadabadi, Abbas Ali Iran J Pharm Res Original Article As global competition intensifies, research and development (R & D) organizations need to enhance their strategic management in order to become goal-directed communities for innovation and allocate their resources consistent with their overall R & D strategy. The world pharmaceutical market has undergone fast, unprecedented, tremendous and complex changes in the last several years. The pharmaceutical industry is today still one of the most inventive, innovative and lucrative of the so-called “high-tech” industries. This industry serves a dual role in modern society. On one hand, it is a growing industry, and its output makes a direct contribution to gross domestic product (GDP). On the other side, drugs, this industry’s major output, are an input in the production of good health. The purpose of this study is to evaluate R & D activities of pharmaceutical companies, and also to highlight critical factors which have influential effect on results of these activities. To run this study a valid questionnaire based on literature review and experts’ opinion was designed and delivered to 11 pharmaceutical companies. Empirical data show there is not acceptable situations considering of the factors that should be taken in to account by managers including; management commitment, human resource management, information technology and financial management. Furthermore, we concluded some interesting results related to different aspects of R & D management. In conclusion, managers must be aware about their performance in R & D activities, accordingly they will able to take a comprehensive policy in both national and within the company. Shaheed Beheshti University of Medical Sciences 2012 /pmc/articles/PMC3813171/ /pubmed/24250532 Text en © 2012 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rasekh, Hamid Reza
Mehralian, Gholamhossein
Vatankhah-Mohammadabadi, Abbas Ali
Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
title Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
title_full Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
title_fullStr Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
title_full_unstemmed Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
title_short Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
title_sort situation analysis of r & d activities: an empirical study in iranian pharmaceutical companies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813171/
https://www.ncbi.nlm.nih.gov/pubmed/24250532
work_keys_str_mv AT rasekhhamidreza situationanalysisofrdactivitiesanempiricalstudyiniranianpharmaceuticalcompanies
AT mehraliangholamhossein situationanalysisofrdactivitiesanempiricalstudyiniranianpharmaceuticalcompanies
AT vatankhahmohammadabadiabbasali situationanalysisofrdactivitiesanempiricalstudyiniranianpharmaceuticalcompanies